Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TAK - Ovid Therapeutics: Residual Value In OV935 After The OV101 Fiasco

TAK - Ovid Therapeutics: Residual Value In OV935 After The OV101 Fiasco

Takeda Pharmaceutical Company Limited American Depositary Shares
  • I recommended OVID for OV935 but disliked OV101. In December, OVID fell drastically after OV101's failure.
  • OV935 thesis still stands, however, the numbers are now different.
  • This article was written after some asked for my current opinion on the stock.

For further details see:

Ovid Therapeutics: Residual Value In OV935 After The OV101 Fiasco
Stock Information
Company Name: Takeda Pharmaceutical Company Limited American Depositary Shares
Stock Symbol: TAK
Market: NYSE
Website: takeda.com
Menu
TAK TAK Quote TAK Short TAK News TAK Articles TAK Message Board
Get TAK Alerts

News, Short Squeeze, Breakout and More Instantly...